The DEA's five-part test to determine 'currently accepted medical use' is flawed, say the plaintiffs.
It’s the latest sign that the world is warming to the health benefits of a plant that for decades has been dismissed as a dangerous drug.
CBD moves from Schedule I to Schedule V, but only for FDA-approved drugs. Everything else is still treated like heroin.
The lawsuit, known as Washington v. Sessions, was brought by five medical cannabis patients. The federal judge sympathized, but had to follow procedural law.
A blockbuster lawsuit in New York could end cannabis prohibition nationwide. Leafly sat down with David Holland, an attorney for the plaintiffs.
A leading veterinary organization is joining the fight to reschedule cannabis in an effort to speed research into the plant’s effects on our furry friends.
Rescheduling cannabis would have dramatically increased costs for smaller players, potentially pushing them out of business.
We've boiled it down to the basics.
The DEA’s announcement that it will remove a major roadblock to cannabis research could spur broader scientific study of a drug already being used to treat conditions in 25 states.